1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Biologics in severe asthma : A pragmatic approach for choosing the right treatment for the right patient
(
- Contribution to journal › Article
-
Mark
Eosinophils—from cradle to grave
(
- Contribution to journal › Article
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
2023) In Allergy: European Journal of Allergy and Clinical Immunology(
- Contribution to journal › Article
- 2019
-
Mark
EUFOREA consensus on biologics for CRSwNP with or without asthma
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Towards precision medicine in severe asthma : Treatment algorithms based on treatable traits
(
- Contribution to journal › Scientific review
-
Mark
Targeting the interleukin-4 and interleukin-13 pathways in severe asthma : Current knowledge and future needs
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Role of biologics targeting type 2 airway inflammation in asthma : What have we learned so far?
(
- Contribution to journal › Scientific review